Home Cart Sign in  
Chemical Structure| 18378-20-6 Chemical Structure| 18378-20-6

Structure of BBD
CAS No.: 18378-20-6

Chemical Structure| 18378-20-6

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

BBD is a biochemical reagent/chromogenic reagent.

Synonyms: NSC240867; Benzylamino-NBD

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of BBD

CAS No. :18378-20-6
Formula : C13H10N4O3
M.W : 270.24
SMILES Code : O=[N+](C1=CC=C(NCC2=CC=CC=C2)C3=NON=C31)[O-]
Synonyms :
NSC240867; Benzylamino-NBD
MDL No. :MFCD00038006
InChI Key :GZFKJMWBKTUNJS-UHFFFAOYSA-N
Pubchem ID :87615

Safety of BBD

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H315-H319-H335
Precautionary Statements:P261-P305+P351+P338

Isoform Comparison

Biological Activity

In Vitro:

Cell Line
Concentration Treated Time Description References
BV-2 cells 1 to 20 μM 30 minutes To assess the inhibitory effect of BBD on hypoxia-induced inflammatory responses. BBD significantly reduced ROS accumulation, IL-1, IL-6, and PGE2 production, and inhibited the activation of JNK MAPK, COX-2, and caspase-3. PMC3975964
PC12 cells 1 to 20 μM 30 minutes To evaluate the protective effect of BBD against hypoxia-induced cytotoxicity. BBD at concentrations of 1 to 20 μM significantly increased cell viability and reduced LDH release in PC12 cells. PMC3975964

Clinical Trial:

NCT Number Conditions Phases Recruitment Completion Date Locations
NCT03464955 Stress, Emotional ... More >> Stress, Psychological Behavioral Symptoms Less << Not Applicable Recruiting October 16, 2019 United States, California ... More >> Lucile Packard Children's Hospital at Stanford Recruiting Palo Alto, California, United States, 94304 Contact: Sam Rodriguez, MD    650-723-5728    sr1@stanford.edu    Contact: Tom J Caruso    650-723-5728    tjcaruso@stanford.edu    Principal Investigator: Sam Rodriguez, MD          Sub-Investigator: Tom J Caruso, MD Less <<
NCT02597764 Bladder and Bowel Disorder, Pe... More >>diatric Less << Not Applicable Completed - Canada, British Columbia ... More >> BC Children's and Women's Hospital Vancouver, British Columbia, Canada, V6H 3N1 Less <<
NCT03220828 Stress, Emotional Not Applicable Recruiting May 11, 2019 United States, California ... More >> Lucile Packard Children's Hospital at Stanford Recruiting Palo Alto, California, United States, 94304 Contact: Sam Rodriguez, MD    650-723-5728    sr1@stanford.edu    Contact: Tom J Caruso    650-723-5728    tjcaruso@stanford.edu    Principal Investigator: Sam Rodriguez, MD          Sub-Investigator: Tom J Caruso, MD Less <<
NCT01308450 - Completed - -
NCT01308450 - Completed - United States, Utah ... More >> The Focus Center Clinton, Utah, United States, 84015 Less <<
NCT01118650 - Withdrawn(No interest from sch... More >>ool district) Less << - -
NCT02432625 - Recruiting June 2025 United States, California ... More >> University of California Los Angeles Recruiting Los Angeles, California, United States, 90095 Contact: Samantha Alon    310-794-6420    SAlon@mednet.ucla.edu    Principal Investigator: Deborah Krakow, MD          United States, District of Columbia Children's National Medical Center Recruiting Washington, District of Columbia, United States, 21205 Contact: Christina Dollar       cdollar@childrensnational.org    Contact: Austin Gillies       ausgillies@gmail.com    Principal Investigator: Laura Tosi, MD          United States, Florida Tampa Shriners Hospital for Children Recruiting Tampa, Florida, United States, 33612 Contact: Margaret Gross-King    813-972-2250 ext 7538    mgking@shrinenet.org    Principal Investigator: Danielle Gomez, MD          United States, Maryland Kennedy Krieger Institute / Hugo W. Moser Research Institute Recruiting Baltimore, Maryland, United States, 21205 Contact: Jennifer Nagy, RN, BSN    443-923-2704    Nagy@kennedykrieger.org    Principal Investigator: Mahim Jain, MD          United States, Nebraska University of Nebraska Medical Center Recruiting Omaha, Nebraska, United States, 68198 Contact: Elizabeth Strudthoff, B.S.    402-559-0681    elizabeth.strudthoff@unmc.edu    Principal Investigator: Paul Esposito, MD          United States, New York Hospital for Special Surgery Recruiting New York, New York, United States, 10021 Contact: Sobiah Khan    212-774-2355    KhanS@HSS.EDU    Principal Investigator: Cathleen Raggio, MD          United States, Oregon Oregon Health and Science University Recruiting Portland, Oregon, United States, 97239 Contact: Catherine Pederson    503-494-0225    pedersec@ohsu.edu    Principal Investigator: Eric Orwoll, MD          United States, Texas Baylor College of Medicine Recruiting Houston, Texas, United States, 77030 Contact: Dianne Dang    713-798-6694    diannen@bcm.edu    Principal Investigator: V.Reid Sutton, MD          United States, Wisconsin Shriners Hospital for Children, Chicago / Marquette University Recruiting Milwaukee, Wisconsin, United States, 53201 Contact: Angela Caudill, MPT    773-385-5868    acaudill@shrinenet.org    Principal Investigator: Peter Smith, MD          Canada, Quebec Shriners Hospital for Children Recruiting Montreal, Quebec, Canada, H3G 1A6 Contact: Michaela Durigova    514-282-7158    mdurigova@shriners.mcgill.ca    Principal Investigator: Frank Rauch, MD          Sub-Investigator: Francis Glorieux, MD Less <<
NCT02424851 Multiple Myeloma ... More >> Chronic Kidney Disease Less << Phase 2 Recruiting June 2019 United Kingdom ... More >> Basingstoke & North Hampshire Hospital Not yet recruiting Basingstoke, United Kingdom Principal Investigator: Noel Ryman          Kent & Canterbury Hospital Recruiting Canterbury, United Kingdom, CT1 3NG Principal Investigator: Jindrinska Lindsay          St Helier Hospital Recruiting Epsom, United Kingdom Principal Investigator: Simon Stern          Royal Liverpool Hospital Recruiting Liverpool, United Kingdom Principal Investigator: Nauman Butt          Churchill Hospital Recruiting Oxford, United Kingdom, OX3 7LE Principal Investigator: Karthik Ramasamy          Queen Alexandra Hospital Recruiting Portsmouth, United Kingdom Contact: Helen Dignum          Principal Investigator: Helen Dignum          Great Western Hospital Suspended Swindon, United Kingdom Less <<
NCT00000231 Opioid-Related Disorders Phase 2 Completed - United States, Vermont ... More >> Treatment Research Center Burlington, Vermont, United States, 05401 Less <<
NCT00000230 Opioid-Related Disorders Phase 2 Completed - United States, Vermont ... More >> Treatment Research Center Burlington, Vermont, United States, 05401 Less <<
NCT03072303 - Active, not recruiting June 30, 2019 United States, Florida ... More >> RDCRN Data Management and Coordinating Center, University of South Florida Tampa, Florida, United States, 33612 Less <<
NCT00000228 Opioid-Related Disorders Phase 2 Completed - United States, Vermont ... More >> Treatment Research Center Burlington, Vermont, United States, 05401 Less <<
NCT00000229 Opioid-Related Disorders Phase 2 Completed - United States, Vermont ... More >> Treatment Research Center Burlington, Vermont, United States, 05401 Less <<
NCT02793063 - Completed - United States, Florida ... More >> University of South Florida, Health Informatics Institute Tampa, Florida, United States, 33612 Less <<
NCT01056276 Multiple Myeloma Phase 2 Completed - United States, California ... More >> Los Robles Hospital and Medical Center Thousand Oaks, California, United States, 91360 United States, Florida Florida Cancer Specialists Ft. Myers, Florida, United States, 33916 United States, Louisiana Hematology Oncology Clinic, LLP Baton Rouge, Louisiana, United States, 70809 United States, Maryland Center for Cancer and Blood Disorders Bethesda, Maryland, United States, 20817 National Capital Clinical Research Consortium Bethesda, Maryland, United States, 20817 United States, Michigan Grand Rapids Clinical Oncology Program Grand Rapids, Michigan, United States, 49503 United States, Ohio Oncology Hematology Care Inc. Cincinnati, Ohio, United States, 45242 United States, South Carolina South Carolina Oncology Associates Columbia, South Carolina, United States, 29210 United States, Tennessee Chattanooga Oncology Hematology Associates Chattanooga, Tennessee, United States, 37404 Tennessee Oncology Nashville, Tennessee, United States, 37203 United States, Texas Leading Edge Research, PA Arlington, Texas, United States, 75213 The Center for Cancer and Blood Disorders Fort Worth, Texas, United States, 76104 United States, Virginia Peninsula Cancer Institute Newport News, Virginia, United States, 23601 Less <<
NCT01056276 - Completed - -
NCT02224729 Stage I Multiple Myeloma ... More >> Stage II Multiple Myeloma Stage III Multiple Myeloma Less << Phase 2 Active, not recruiting January 2020 United States, Pennsylvania ... More >> Thomas Jefferson University Philadelphia, Pennsylvania, United States, 19107 Less <<
NCT02224729 - Active, not recruiting - -
NCT01168804 Multiple Myeloma Phase 2 Completed - Austria ... More >> Medical University Hospital Graz Graz, Austria, 8036 Hospital Elisabethinen Linz Linz, Austria, 4010 LKH Salzburg, 3rd Med. Dept. Salzburg, Austria, 5020 Med. University Vienna, Clinic for Internal Medicine 1 (Hematology and Hemostaseology) Vienna, Austria, 1090 Hanusch Hospital Vienna Vienna, Austria, 1140 Wilhelminenspital Vienna Vienna, Austria, 1160 Clinic Wels-Grieskirchen, 4th Internal Dept. Wels, Austria, 4600 Czech Republic Faculty Hospital Brno Brno, Czech Republic, 63900 Less <<

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

3.70mL

0.74mL

0.37mL

18.50mL

3.70mL

1.85mL

37.00mL

7.40mL

3.70mL

 

Historical Records